Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0794
-0.0016 (-1.98%)
Sep 15, 2025, 3:50 PM EDT
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $6.01 million as of September 15, 2025. Its market cap has decreased by -48.13% in one year.
Market Cap
6.01M
Enterprise Value
5.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 6.01M, a decrease of -94.44%. That is a compound annual growth rate of -7.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 5.69M | -50.86% |
Dec 31, 2024 | 11.58M | 66.86% |
Dec 29, 2023 | 6.94M | -62.07% |
Dec 30, 2022 | 18.31M | -27.99% |
Dec 31, 2021 | 25.42M | 37.89% |
Dec 31, 2020 | 18.43M | 102.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 789.71M |
Elite Pharmaceuticals | 750.21M |
Tian'an Technology Group | 723.74M |
Glass House Brands | 566.73M |
Northwest Biotherapeutics | 390.10M |
CytoDyn | 358.38M |
American Oncology Network | 353.52M |